John J Orloff - Net Worth and Insider Trading
John J Orloff Net Worth
The estimated net worth of John J Orloff is at least $6 Million dollars as of 2024-05-04. John J Orloff is the EVP, Research & Development of Alexion Pharmaceuticals Inc and owns about 31,790 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. Details can be seen in John J Orloff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John J Orloff has not made any transactions after 2018-06-08 and currently still holds the listed stock(s).
Transaction Summary of John J Orloff
John J Orloff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John J Orloff owns 4 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Novelion Therapeutics Inc (NVLNF) , and Aegerion Pharmaceuticals Inc (AEGR) among others .
Click here to see the complete history of John J Orloff’s form 4 insider trades.
Insider Ownership Summary of John J Orloff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-06-08 | EVP & Research & Development |
| NVLNF | Novelion Therapeutics Inc | 2018-08-09 | director |
| AEGR | Aegerion Pharmaceuticals Inc | 2016-11-01 | EVP & Research and Development |
 | | 2016-06-03 | See Remarks |
John J Orloff Latest Holdings Summary
John J Orloff currently owns a total of 1 stock. John J Orloff owns 31,790 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $6 Million.
Latest Holdings of John J Orloff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2018-06-08 | 31,790 | 182.50 | 5,801,675 |
Holding Weightings of John J Orloff
John J Orloff Form 4 Trading Tracker
According to the SEC Form 4 filings, John J Orloff has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 2,115 shares on June 8, 2018, which brought John J Orloff around $250,691.
Insider Trading History of John J Orloff
- 1
John J Orloff Trading Performance
John J Orloff Ownership Network
John J Orloff Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
John J Orloff is the EVP & Research & Development of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
John J Orloff Mailing Address
Above is the net worth, insider trading, and ownership report for John J Orloff. You might contact John J Orloff via mailing address: C/o Baxalta Incorporated 1200 Lakeside Drive Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
